蜜桃传媒

An article distributed by Reuters Health reports that pooled data from randomized trials does not clearly demonstrate a significant advantage for thromboprophylaxis in cancer patients with central venous catheters and quotes lead investigator Elie A. Akl, assistant professor of medicine.